Namenda (Memantine) — Patient Guide (UK)

Namenda contains memantine, a medicine used to treat symptoms of moderate to severe Alzheimer’s disease. It works by helping to regulate activity of certain nerve signals in the brain. This page explains how Namenda works, how it is typically used in the UK, and what to consider for safety, timing, food, alcohol, and interactions.

Note: Always follow the advice given by your clinician and read the Patient Information Leaflet supplied with your specific medicine and pack.

Basic product information

• Medicine name: Namenda (memantine)
• Active ingredient: Memantine (often as memantine hydrochloride)
• Common form: Tablets (brand and strength may vary by supplier)
• Also known as: Memantine is available as generic versions in the UK
• Medicine type: Symptomatic treatment for Alzheimer’s disease (not a cure)
• Who it’s for: People with moderate to severe Alzheimer’s disease

What Namenda is used for (indications)

In the UK, memantine is used to treat symptoms of:

• Moderate to severe Alzheimer’s disease

In some treatment plans, memantine may be used alongside other medicines for Alzheimer’s disease (for example, cholinesterase inhibitors) depending on individual circumstances and tolerability.

How Namenda works (mechanism of action)

Alzheimer’s disease affects brain cells involved in memory, thinking, and daily functioning. In Alzheimer’s, there may be abnormal activity of brain receptors that use the chemical glutamate.

Memantine is an NMDA receptor antagonist. In simple terms:

• It helps to regulate over-activation of NMDA (N-methyl-D-aspartate) receptors.
• This may reduce excessive nerve signalling that can contribute to brain cell stress.
• The goal is to help improve or maintain cognitive function and daily living abilities for some people, though effects vary.

Important: Namenda does not stop Alzheimer’s disease from progressing, but it may help slow symptom worsening for some individuals.

Pharmacokinetics (how the body handles memantine)

Pharmacokinetics describes what the body does to a medicine (absorption, distribution, metabolism, and elimination). Key points for memantine include:

• Absorption: Memantine is absorbed after oral administration.
• Distribution: It distributes into tissues, including the brain.
• Metabolism: A relatively small portion is metabolised.
• Elimination: Memantine is primarily eliminated via the kidneys (renal excretion).
• Half-life: Memantine has a long duration of action, supporting once-daily or twice-daily dosing depending on the regimen and formulation.

Kidney function matters: Because memantine is cleared through the kidneys, people with moderate to severe kidney impairment may need dose adjustments and closer monitoring.

Typical dosing and timing

How quickly your dose increases can affect tolerability. Most people start on a low dose and increase gradually.

Common UK approach (general guidance): Doses are usually adjusted over several weeks to reach a maintenance dose. Exact strengths and titration schedules may differ between products, so follow your prescribed plan.

General timing advice

• Take at the same time(s) each day to keep medicine levels steady.
• If prescribed once daily, take it in the morning or evening as directed.
• If prescribed twice daily, distribute doses evenly (for example, morning and evening).
• Do not double up to make up for a missed dose unless your clinician advises it.

Missed dose (practical guidance)

• If you miss a dose, take it when you remember unless it is close to the next dose.
• If close, skip the missed dose and continue with the next scheduled dose.
• If you are unsure, check your leaflet or speak to a pharmacist.

Food interactions and whether to take with meals

Memantine can generally be taken with or without food.

• With meals: Many people find it easier to tolerate with food if they experience stomach upset.
• Without meals: It may also be taken as directed on an empty stomach if tolerated.

Food is not a major expected driver of interaction, but consistency in how you take the medicine may help you remember and maintain a steady routine.

Alcohol interactions

There is no single universal “safe” rule for alcohol with memantine, because individual risk can vary (for example, based on other medicines, liver/kidney health, age, fall risk, and overall cognitive status).

General considerations:

• Alcohol can worsen confusion, dizziness, and drowsiness, which may be more concerning in Alzheimer’s disease.
• Mixing alcohol with any medicine that affects the brain may increase side effects.

Practical advice: If you drink alcohol, do so cautiously and consider keeping intake modest. If you notice increased dizziness or confusion after drinking, avoid alcohol and seek advice from a healthcare professional.

Medicine interactions (including important classes)

Some medicines can affect how memantine works or increase side effects. Tell your pharmacist or clinician about all medicines you take, including:

• Prescription medicines
• Over-the-counter products
• Herbal remedies
• Supplements

Key interaction themes for memantine include:

1) Medicines that affect urine pH

Memantine elimination is influenced by urine acidity. Medicines that raise or lower urine pH may alter memantine levels.

• Examples (conceptual): Certain urinary alkalinising agents or other medicines can change urine pH.

What to do: Let your clinician know about any medicine intended to affect urination or urine chemistry.

2) NMDA-related medicines

Because memantine targets the NMDA receptor system, combining with medicines that have similar effects may increase side effects.

• Examples: Ketamine, dextromethorphan (and other NMDA-related agents) may be relevant.

3) Medicines for Parkinson’s disease

Some Parkinson’s medicines work through dopamine pathways; memantine may affect symptom balance for some people.

• Examples: Levodopa and dopamine agonists may be relevant to discuss.

4) Other dementia medicines

Memantine is sometimes used together with cholinesterase inhibitors. This is not automatically unsafe, but tolerability should be monitored.

• Examples: Donepezil, rivastigmine, galantamine (as used in Alzheimer’s care)

5) “General CNS effects”

Memantine may cause dizziness or sleepiness in some people. Combining with medicines that also cause these effects can increase risk of falls or impaired driving.

• Sleep medicines
• Strong pain medicines (opioids)
• Some sedating antihistamines

Seek advice promptly if you start new medicines and you notice new or worsening dizziness, confusion, or unsteadiness.

Safety profile: side effects and when to get help

Like all medicines, memantine can cause side effects. Many are mild and improve as your body adjusts, especially during dose titration.

Common side effects

• Dizziness
• Headache
• Constipation
• Confusion (may be difficult to separate from the condition itself)
• Sleepiness or unusual fatigue

Less common but important effects

• Hallucinations (seeing or hearing things that are not there)
• Unsteadiness or falls
• Shortness of breath or swelling (rare; could indicate a serious reaction)

Seek urgent medical advice if

• You develop signs of an allergic reaction (for example, rash with swelling, difficulty breathing, or sudden worsening)
• There is a significant change in consciousness, severe agitation, or severe confusion beyond baseline
• There are troublesome side effects that don’t improve or that affect daily safety

Monitoring: People starting memantine and those with kidney impairment may require closer monitoring for side effects.

Practical use tips (making Namenda easier to take)

• Use a daily routine: Pair the dose with a fixed activity (breakfast, brushing teeth, or evening routine).
• Consider a pill organiser: Weekly organisers can reduce missed doses.
• Track side effects: If dizziness or constipation occurs, note timing relative to doses and share with your clinician.
• Hydration: Staying adequately hydrated may support overall tolerance, particularly if constipation occurs.
• Falls prevention: If dizziness is present, avoid rushing to stand and review footwear and home trip hazards.
• Support carers: If you are a family member or carer, gentle supervision during dose changes can improve adherence and safety.

Kidney and other special considerations

Because memantine is removed mainly by the kidneys, dosing may require adjustment in renal impairment.

• Before starting: Your healthcare professional may review kidney function tests.
• During treatment: Monitoring may be needed if kidney function declines over time.
• Discuss other conditions: Report any history of seizures, severe neurological conditions, or major changes in health.

Alternative options (other medicines and approaches)

For Alzheimer’s disease, there are several medication options depending on the stage and individual circumstances.

Other drug treatments

• Cholinesterase inhibitors (often used in mild to moderate Alzheimer’s, and sometimes continued later): donepezil, rivastigmine, galantamine.
• Combination therapy: in some people, memantine is used alongside a cholinesterase inhibitor.

Non-medicine support

• Cognitive stimulation and structured activities
• Physical activity tailored to ability
• Sleep routine and management of behavioural symptoms where safe
• Care planning for safety, communication, and daily support

Your clinician can help choose the best overall plan based on symptoms, tolerability, stage of illness, and other health conditions.

Guidance and monitoring in the UK (recent and practical context)

In the UK, Alzheimer’s disease management typically follows evidence-based guidance issued by healthcare bodies and professional organisations. In practice, this usually involves:

• Regular review of benefit and tolerability after starting or increasing doses.
• Monitoring for side effects, especially dizziness, constipation, sleepiness, and confusion changes.
• Assessment of kidney function where relevant, since memantine is renally cleared.
• Support for carers to ensure adherence and to identify problems early.

Because guidance can evolve over time, and because local prescribing policies may vary, it is best to confirm details with your clinician or pharmacist.

Dosing details (overview table)

Doses vary by patient factors, kidney function, and the specific product. The table below provides an overview of dosing concepts commonly used with memantine, rather than a substitute for your individual plan.

Market and legal context in the United Kingdom

Memantine medicines are available in the UK and can be obtained through legitimate pharmacy channels, including online pharmacies that comply with UK regulations.

• Regulatory status: Memantine is an established medicine used in Alzheimer’s disease care.
• Quality and authenticity: Buy from reputable suppliers to reduce the risk of counterfeit or non-compliant products.
• Brand and generic availability: Namenda and generic memantine products may have different pack sizes and strengths.
• Information requirement: Reputable online pharmacies provide access to patient leaflets and clear medicine information.

Tip: If you switch brands or strengths, double-check the dose and schedule on the pack and ask a pharmacist if anything is unclear.

Delivery and availability (UK)

Availability can vary by strength and pack size. Many UK pharmacies offer:

• Standard delivery and/or next-day options depending on the supplier and location.
• Real-time stock checks at the time of order.
• Discrete packaging to protect privacy.

If your preferred product is not available immediately, ask about:

• Alternative memantine strengths
• Generic equivalents
• Delivery lead times

FAQ — Namenda (memantine) for Alzheimer’s disease

1) How long does Namenda take to work?

Some people may notice changes over weeks, while others may not experience clear differences. The medicine is usually reviewed after an appropriate trial period as recommended by the treating team. Continued use is typically based on overall benefit and tolerability.

2) Is Namenda a cure for Alzheimer’s disease?

No. Namenda is a symptomatic treatment. It aims to help maintain function and manage symptoms, not cure the condition.

3) Can I stop Namenda if I feel better?

Do not stop or change your dose without medical advice. Stopping may worsen symptoms for some people. If side effects occur, your clinician can advise on adjustments or alternative options.

4) What if someone forgets a dose?

Take the missed dose only if it is not close to the next scheduled dose. If it is near the next dose, skip the missed dose and continue as planned. Avoid double dosing.

5) Does memantine cause drowsiness?

Some people experience dizziness or sleepiness. If you notice these effects, be cautious with driving, operating machinery, or activities where dizziness could increase fall risk.

6) Can it be taken with food?

Generally, yes. Memantine can usually be taken with or without food. Choose a routine you can manage consistently.

7) Are there interactions with other dementia medicines?

Memantine may be used with other Alzheimer’s medications in some regimens. Your pharmacist or clinician should check for interactions and monitor for tolerability.

8) Is it safe to drink alcohol while taking memantine?

Alcohol may increase side effects like dizziness or confusion. If you choose to drink, do so cautiously and keep intake modest. Avoid alcohol if you notice worsening symptoms or increased unsteadiness.

9) Who should be extra careful with memantine?

People with kidney impairment and those who are prone to dizziness, falls, or confusion should be monitored closely. Inform your clinician and pharmacist about all other medicines and health conditions.

10) Are there alternatives to Namenda?

Depending on stage and symptoms, alternatives may include other Alzheimer’s medicines (such as cholinesterase inhibitors) and non-drug support strategies. Your clinician can advise what is appropriate for your situation.

Always read: the pack leaflet for your exact product and strength, and seek professional advice if you have questions about suitability, side effects, or interactions.